NanoThea’s technology utilizes an advanced radioisotope delivery system for targeting cancer cells, compatible with a wide range of therapeutic and diagnostic radioisotopes. Thanks to our sophisticated technology, we can precisely direct radioactive substances to diseased areas, ensuring better treatment outcomes. Key Features of Our Technology: - Safe polymer carrier - Increased penetration, retention, and targeting factors that allow nanoparticles to accumulate within tumor tissues - Proven non-toxicity and biocompatibility of the carrier - Versatility - Theranostic approach: We offer tools that combine diagnostics with therapeutic applications - Ability to use various chelators, enabling the delivery of a wide range of radioisotopes such as: 99mTc, 111In, 177Lu, 90Y, 166Ho, 64Cu/67Cu, 68Ga
